The Effect of Cold Application on Nausea and Vomiting in the Early Postoperative Period

NCT ID: NCT05888818

Last Updated: 2023-06-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-01

Study Completion Date

2024-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As a result of the literature review, it has been seen that it has not yet been clarified whether cold application methods are effective on postoperative nausea and vomiting, and academic studies on this subject are needed.

The aim of the planned study was to conduct a randomized controlled experimental study to evaluate the effect of the cold application method on nausea and vomiting and the need for antiemetic drugs in the early postoperative period.

The research hypotheses are as follows:

H1:Cold application method reduces nausea and vomiting in the early postoperative period.

H1:The cold application method reduces the need for antiemetic drugs in the early postoperative period.

H1:Cold application method in the early postoperative period increases patient satisfaction.

Condition or disease:

Postoperative nausea and vomiting,Postoperative antiemetic use status,Patient satisfaction,Effects of cold application method

Intervention/treatment:

There is an intervention group in which the cold application method is applied.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the planned study was to conduct a randomized controlled experimental study to evaluate the effect of the cold application method on nausea and vomiting and the need for antiemetic drugs in the early postoperative period.

The population of the study will consist of patients who are planned to undergo laparoscopic cholecystectomy under general anesthesia in the Department of General Surgery, Zonguldak Bülent Ecevit University Health Practice and Research Center between October 2022 and October 2024.Çalışmanın örneklemini laparoskopik kolesistektomi planlanan, dahil edilme kriterlerini karşılayan ve çalışmaya katılmaya gönüllü olan hastalar oluşturacaktır.

As a result of the GPower power analysis, it was calculated that at least 60 people (at least 30 people for each group) who met the inclusion criteria of the research should be taken in order to obtain 80% power at the 95% confidence interval for the d=0.8 effect size.

Data collecting:

The collection of research data will be carried out in three stages.

1. stage:Patients scheduled for laparoscopic cholecystectomy who have undergone hospitalization will be evaluated in terms of their eligibility for inclusion criteria, and eligible patients will be invited to participate in the study.The purpose of the research will be explained to the patients, the informed consent form will be read, written and verbal consent will be obtained and a copy of the form will be given to the patients.Then, the patient information data collection form and Apfel risk score will be filled with face-to-face interview technique, and the answers given by the patients will be recorded.
2. stage: The surgery will be held in the recovery room.While the patients in the intervention group are in the recovery room after the surgery, their routine applications will be made and the state of consciousness and alertness will be checked.After the application, the presence of nausea, severity, vomiting status, vital signs (blood pressure, pulse, respiratory rate, body temperature) will be measured.Then, a cold application (with a cold gel pack) will be applied to the nape area for 5 minutes.Presence of nausea, severity, vomiting status, vital signs will be re-measured immediately after the application.Antiemetic drug use and opioid drug use will be questioned.
3. stage:Presence, severity and presence of nausea will be re-evaluated at the 2nd and 6th hours of the experimental and control group patients.Antiemetic drug use and opioid drug use will be questioned.Patient satisfaction will be evaluated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Local Application/Packing Too Cold Patient Satisfaction Postoperative Nausea and Vomiting

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

There is an experimental and a control group.The distribution of the patients to the groups was made according to the random numbers table obtained by using the index formulas and randomly in the excel program in the web environment.
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cold application group

A cold application (with a cold gel pack) will be applied to the upper part of the neck for 5 minutes.

Group Type EXPERIMENTAL

Cold application

Intervention Type OTHER

A cold application (with a cold gel pack) will be applied to the upper part of the neck for 5 minutes.

standard treatment

No application will be made and the presence of nausea, severity, vomiting and vital signs will be measured after 5 minutes.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cold application

A cold application (with a cold gel pack) will be applied to the upper part of the neck for 5 minutes.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Those who will undergo elective surgery
* Attempting laparoscopic cholecystectomy
* Those between the ages of 18-65
* Those who will receive general anesthesia
* Not allergic to cold
* Body temperature ≥36°C
* ASA I and ASA II class
* Those with an Apfel risk score of 2 and above
* Postoperative nausea severity of 2 and above
* Without chronic disease
* Neurological problems
* No problem communicating,• No hearing and vision problems
* Being conscious, awake and oriented after surgery,
* Patients who volunteer to participate in the study will be included in the study

* Patients who do not volunteer to participate in the study will not be included in the study.

Exclusion Criteria

* Those who are allergic to cold
* Body temperature \<36°C,
* Those who have a disability, incision and surgical procedure around the head and neck
* Having chronic illness
* Having neurological problems
* Having nasogastric tube
* Postoperatively conscious, awake and not oriented,
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zonguldak Bulent Ecevit University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nigar Ak Turkis

Doctoral Candidate in Surgical Nursing Science

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nigar AK TURKİS, PhD student

Role: PRINCIPAL_INVESTIGATOR

Zonguldak Bulent Ecevit University,PhD student

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zonguldak Bulent Ecevit University

Zonguldak, Kozlu, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nigar AK TURKİS, PhD student

Role: CONTACT

+905066926811

Nurten TASDEMİR, associate professor

Role: CONTACT

+905072344018

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nigar AK TURKİS, PhD student

Role: primary

+905066926811

Nurten TASDEMİR, associate professor

Role: backup

+905072344018

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022/16-08

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.